{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:48:22Z","timestamp":1793620102512,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1180069"],"award-info":[{"award-number":["1180069"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.semcancer.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:26:37Z","timestamp":1589657197000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery"],"prefix":"10.1016","volume":"80","author":[{"given":"F\u00e9lix A.","family":"Urra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Araya-Maturana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14789450.2018.1500904","article-title":"Snake venomics \u2013 from low-resolution toxin-pattern recognition to toxin-resolved venom proteomes with absolute quantification","volume":"15","author":"Calvete","year":"2018","journal-title":"Expert Rev. Proteomics"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.006_bib0015","doi-asserted-by":"crossref","first-page":"E290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbagen.2016.12.022","article-title":"Minor snake venom proteins: structure, function and potential applications","volume":"1861","author":"Boldrini-Fran\u00e7a","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fevo.2019.00279","article-title":"Venoms of rear-fanged snakes: new proteins and novel activities","volume":"7","author":"Modahl","year":"2019","journal-title":"Front. Ecol. Evol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15569543.2014.942040","article-title":"Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads","volume":"33","author":"Saviola","year":"2014","journal-title":"Toxin Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-pathol-020117-044127","article-title":"Cancer metastasis: a reappraisal of its underlying mechanisms and their relevance to treatment","volume":"13","author":"Riggi","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","article-title":"Migrastatics-anti-metastatic and anti-invasion drugs: promises and challenges","volume":"3","author":"Gandalovicova","year":"2017","journal-title":"Trends Cancer"},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41416-019-0536-0","article-title":"Solid cancer: the new tumour spread endpoint opens novel opportunities","volume":"121","author":"Fernandes","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxicon.2018.01.015","article-title":"L-amino acid oxidase from snake venom and its anticancer potential","volume":"144","author":"Tan","year":"2018","journal-title":"Toxicon"},{"issue":"17","key":"10.1016\/j.semcancer.2020.05.006_bib0065","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/0929867324666170605091546","article-title":"Snake venom: from deadly toxins to life-saving therapeutics","volume":"24","author":"Waheed","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/0929866525666180614112935","article-title":"Snake venom as an effective tool against colorectal cancer","volume":"25","author":"Uzair","year":"2018","journal-title":"Protein Pept. Lett."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0075","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2174\/0929866524666180614102104","article-title":"Applications of venom proteins as potential anticancer agents","volume":"25","author":"Ejaz","year":"2018","journal-title":"Protein Pept. Lett."},{"issue":"30","key":"10.1016\/j.semcancer.2020.05.006_bib0080","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2174\/1568026619666181221120817","article-title":"Animal venoms have potential to treat cancer","volume":"18","author":"Chatterjee","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112255","article-title":"A systematic review on Piper longum L.: bridging traditional knowledge and pharmacological evidence for future translational research","volume":"247","author":"Yadav","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"59","key":"10.1016\/j.semcancer.2020.05.006_bib0090","doi-asserted-by":"crossref","first-page":"100908","DOI":"10.18632\/oncotarget.21740","article-title":"Venom-based peptide therapy: insights into anti-cancer mechanism","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.006_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10090346","article-title":"Snake venoms in cancer therapy: past, present and future","volume":"10","author":"Li","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/15569543.2017.1399278","article-title":"Snake venom: kill and cure","volume":"38","author":"Akef","year":"2019","journal-title":"Toxin Rev."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.006_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9120390","article-title":"Targeting metastasis with snake toxins: molecular mechanisms","volume":"9","author":"Urra","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fonc.2018.00500","article-title":"The influence of metabolism on drug response in Cancer","volume":"8","author":"Zaal","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0120","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"20","key":"10.1016\/j.semcancer.2020.05.006_bib0125","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1016\/j.bmc.2006.06.025","article-title":"Biochemical and functional characterization of an L-amino acid oxidase isolated from Bothrops pirajai snake venom","volume":"14","author":"Izidoro","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0130","doi-asserted-by":"crossref","first-page":"42673","DOI":"10.1038\/srep42673","article-title":"CR-LAAO, an L-amino acid oxidase from Calloselasma rhodostoma venom, as a potential tool for developing novel immunotherapeutic strategies against cancer","volume":"7","author":"Costa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijbiomac.2016.01.069","article-title":"CR-LAAO antileukemic effect against Bcr-Abl(+) cells is mediated by apoptosis and hydrogen peroxide","volume":"86","author":"Burin","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0140","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1476-18","article-title":"BjussuLAAO-II induces cytotoxicity and alters DNA methylation of cell-cycle genes in monocultured\/co-cultured HepG2 cells","volume":"25","author":"Machado","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2018.05.005","article-title":"CR-LAAO causes genotoxic damage in HepG2 tumor cells by oxidative stress","volume":"404\u2013405","author":"Costa","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijbiomac.2017.05.025","article-title":"A new l-amino acid oxidase from Bothrops jararacussu snake venom: isolation, partial characterization, and assessment of pro-apoptotic and antiprotozoal activities","volume":"103","author":"Carone","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijbiomac.2019.01.059","article-title":"Cytotoxic, genotoxic, and oxidative stress-inducing effect of an l-amino acid oxidase isolated from Bothrops jararacussu venom in a co-culture model of HepG2 and HUVEC cells","volume":"127","author":"Machado","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0160","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41598-018-37435-4","article-title":"L-amino acid oxidase from Bothrops atrox snake venom triggers autophagy, apoptosis and necrosis in normal human keratinocytes","volume":"9","author":"Costal-Oliveira","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbagen.2011.04.003","article-title":"Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from Bothrops leucurus venom","volume":"1810","author":"Naumann","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxicon.2017.10.001","article-title":"Biochemical, biological and molecular characterization of an L-Amino acid oxidase (LAAO) purified from Bothrops pictus Peruvian snake venom","volume":"139","author":"Lazo","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxicon.2017.09.012","article-title":"In vitro cytotoxicity of L-amino acid oxidase from the venom of Crotalus mitchellii pyrrhus","volume":"139","author":"Tan","year":"2017","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061388","article-title":"Cytotoxic, anti-proliferative and apoptosis activity of l-amino acid oxidase from Malaysian Cryptelytrops purpureomaculatus (CP-LAAO) venom on human colon cancer cells","volume":"23","author":"Zainal Abidin","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bcpt.13060","article-title":"Cytotoxic, antiproliferative and apoptosis-inducing activity of L-amino acid oxidase from Malaysian Calloselasma rhodostoma on human colon cancer cells","volume":"123","author":"Zainal Abidin","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jep.2017.11.026","article-title":"Isolation and pharmacological characterization of a new cytotoxic L-amino acid oxidase from Bungarus multicinctus snake venom","volume":"213","author":"Lu","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0195","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijbiomac.2019.05.174","article-title":"L-amino acid oxidase isolated from Micrurus mipartitus snake venom (MipLAAO) specifically induces apoptosis in acute lymphoblastic leukemia cells mostly via oxidative stress-dependent signaling mechanism","volume":"134","author":"Bedoya-Medina","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.toxicon.2018.06.064","article-title":"l-Amino acid oxidase from Cerastes vipera snake venom: isolation, characterization and biological effects on bacteria and tumor cell lines","volume":"150","author":"Salama","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2012.09.006","article-title":"Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins","volume":"62","author":"Gutierrez","year":"2013","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.toxicon.2012.02.007","article-title":"Snake venom Lys49 myotoxins: from phospholipases A(2) to non-enzymatic membrane disruptors","volume":"60","author":"Lomonte","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.toxicon.2019.07.004","article-title":"Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: comparative characterization and synergism between Asp49 and Lys49 variants","volume":"168","author":"Bustillo","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.05.164","article-title":"Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells","volume":"135","author":"de Vasconcelos Azevedo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40409-015-0044-5","article-title":"Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines","volume":"21","author":"Prinholato da Silva","year":"2015","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"Pt A","key":"10.1016\/j.semcancer.2020.05.006_bib0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijbiomac.2018.06.082","article-title":"Genotoxic effects of BnSP-6, a Lys-49 phospholipase A2 (PLA2) homologue from Bothrops pauloensis snake venom on MDA-MB-231 breast cancer cells","volume":"118","author":"Silva","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijbiomac.2015.10.080","article-title":"Human breast cancer cell death induced by BnSP-6, a Lys-49 PLA(2) homologue from Bothrops pauloensis venom","volume":"82","author":"Azevedo","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"39","key":"10.1016\/j.semcancer.2020.05.006_bib0240","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.2174\/1381612822666160719122626","article-title":"Determinants of anti-cancer effect of mitochondrial electron transport chain inhibitors: bioenergetic profile and metabolic flexibility of cancer cells","volume":"22","author":"Urra","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fonc.2017.00118","article-title":"The mitochondrial complex(I)ty of cancer","volume":"7","author":"Urra","year":"2017","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0250","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF02138304","article-title":"Isolation from cobra venom of a factor inhibiting glycolysis in Ehrlich ascites carcinoma cells","volume":"24","author":"Brisbois","year":"1968","journal-title":"Experientia"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/191144a0","article-title":"Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism","volume":"191","author":"Mitchell","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0260","series-title":"Alkaloids: Biosynthesis, Biological Roles and Health Benefits","first-page":"1","article-title":"Targeting mitochondrial bioenergetics of cancer cells with alkaloids: mechanisms and anti-cancer strategies","author":"Urra","year":"2015"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0265","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fphar.2018.00922","article-title":"Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment","volume":"9","author":"Battogtokh","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0270","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020407","article-title":"Complex mitochondrial dysfunction induced by TPP(+)-gentisic acid and mitochondrial translation inhibition by doxycycline evokes synergistic lethality in breast cancer cells","volume":"9","author":"Fuentes-Retamal","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.006_bib0275","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11030152","article-title":"Naja mossambica mossambica cobra cardiotoxin targets mitochondria to disrupt mitochondrial membrane structure and function","volume":"11","author":"Zhang","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0280","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.toxicon.2007.11.024","article-title":"Taiwan cobra cardiotoxins induce apoptotic death of human neuroblastoma SK-N-SH cells mediated by reactive oxygen species generation and mitochondrial depolarization","volume":"51","author":"Chen","year":"2008","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0290","doi-asserted-by":"crossref","first-page":"45076","DOI":"10.1038\/srep45076","article-title":"Acute and chronic mitochondrial respiratory chain deficiency differentially regulate lysosomal biogenesis","volume":"7","author":"Fernandez-Mosquera","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0295","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190099","article-title":"The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? (dagger)","volume":"9","author":"Vara-Ciruelos","year":"2019","journal-title":"Open Biol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.006_bib0300","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090527","article-title":"Naja atra cardiotoxin 3 elicits autophagy and apoptosis in U937 human leukemia cells through the Ca(2+)\/PP2A\/AMPK axis","volume":"11","author":"Chiou","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"38","key":"10.1016\/j.semcancer.2020.05.006_bib0305","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2174\/138161211798999429","article-title":"Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties","volume":"17","author":"Radis-Baptista","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"Pt 10","key":"10.1016\/j.semcancer.2020.05.006_bib0310","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1107\/S0907444913018003","article-title":"Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus","volume":"69","author":"Coronado","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"20","key":"10.1016\/j.semcancer.2020.05.006_bib0315","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/jp411886u","article-title":"Interaction of the rattlesnake toxin crotamine with model membranes","volume":"118","author":"Costa","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0320","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/mp2000605","article-title":"The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells","volume":"9","author":"Nascimento","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.03.007","article-title":"Mechanistic insights into functional characteristics of native crotamine","volume":"146","author":"Batista da Cunha","year":"2018","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0330","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2010.06.007","article-title":"Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria","volume":"142","author":"Cardenas","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fonc.2017.00055","article-title":"The unfolded protein response: at the intersection between endoplasmic reticulum function and mitochondrial bioenergetics","volume":"7","author":"Carreras-Sureda","year":"2017","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.006_bib0340","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0345","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.celrep.2016.02.030","article-title":"Selective vulnerability of cancer cells by inhibition of Ca(2+) transfer from endoplasmic reticulum to mitochondria","volume":"14","author":"Cardenas","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0350","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neo.2018.03.005","article-title":"Role of mitochondria-associated er membranes in calcium regulation in cancer-specific settings","volume":"20","author":"Morciano","year":"2018","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0355","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbamcr.2019.01.009","article-title":"ER-mitochondria interactions: both strength and weakness within cancer cells","volume":"1866","author":"Doghman-Bouguerra","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0360","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijbiomac.2020.03.055","article-title":"Fibrinogen-clotting enzyme, pictobin, from Bothrops pictus snake venom. Structural and functional characterization","volume":"153","author":"Vivas-Ruiz","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182374","article-title":"Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets","volume":"12","author":"Corona de la Pena","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-030-22254-3_15","article-title":"Tumor dormancy and slow-cycling cancer cells","volume":"1164","author":"Davis","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0375","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3389\/fonc.2018.00677","article-title":"\u201cEnergetic\u201d cancer stem cells (e-CSCs): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy","volume":"8","author":"Fiorillo","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2017.03.003","article-title":"The challenge of targeting cancer stem cells to halt metastasis","volume":"44","author":"Agliano","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0385","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0300-9084(00)01150-0","article-title":"Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu","volume":"82","author":"Andriao-Escarso","year":"2000","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.006_bib0390","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0041-0101(95)00085-Z","article-title":"Phospholipase A2 myotoxins from Bothrops snake venoms","volume":"33","author":"Gutierrez","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0395","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0010","article-title":"BthTX-I from Bothrops jararacussu induces apoptosis in human breast cancer cell lines and decreases cancer stem cell subpopulation","volume":"25","author":"Bezerra","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0400","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1038\/s41598-018-28846-4","article-title":"Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A2 and mediates its toxic activity","volume":"8","author":"Massimino","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0405","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/195356","article-title":"Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells","volume":"2014","author":"de Moura","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0410","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A(2) isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0415","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40409-018-0180-9","article-title":"Cytotoxic and pro-apoptotic action of MjTX-I, a phospholipase A2 isolated from Bothrops moojeni snake venom, towards leukemic cells","volume":"24","author":"Benati","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.006_bib0420","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbagen.2017.11.019","article-title":"Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin","volume":"1862","author":"Hammouda","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0425","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","article-title":"Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia","volume":"7","author":"Weisberg","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0430","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","article-title":"BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review","volume":"34","author":"An","year":"2010","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0435","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.leu.2404236","article-title":"Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)","volume":"20","author":"Nicolini","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0440","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bcpt.12073","article-title":"L-amino acid oxidase isolated from Bothrops pirajai induces apoptosis in BCR-ABL-positive cells and potentiates imatinib mesylate effect","volume":"113","author":"Burin","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5687","key":"10.1016\/j.semcancer.2020.05.006_bib0445","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.1101637","article-title":"Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways","volume":"305","author":"Sordella","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0450","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1742-4658.2009.07450.x","article-title":"EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors","volume":"277","author":"Takeuchi","year":"2010","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0455","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13046-018-0798-z","article-title":"ER-alpha36 mediates cisplatin resistance in breast cancer cells through EGFR\/HER-2\/ERK signaling pathway","volume":"37","author":"Zhu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7605","key":"10.1016\/j.semcancer.2020.05.006_bib0460","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0465","doi-asserted-by":"crossref","first-page":"14768","DOI":"10.1038\/ncomms14768","article-title":"Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer","volume":"8","author":"Uchibori","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0470","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2015.04.001","article-title":"EGFR and NF-kappaB: partners in cancer","volume":"21","author":"Shostak","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0475","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.gastro.2017.03.053","article-title":"EGFR in tumor-associated myeloid cells promotes development of colorectal cancer in mice and associates with outcomes of patients","volume":"153","author":"Srivatsa","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0480","first-page":"319","article-title":"Resolution of gastric cancer-promoting inflammation: a novel strategy for anti-cancer therapy","volume":"421","author":"Piazuelo","year":"2019","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.006_bib0485","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0006-2952(96)00097-4","article-title":"Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanism","volume":"51","author":"Donato","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0490","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/BF02256134","article-title":"Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production","volume":"11","author":"Tseng","year":"2004","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0495","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxicon.2016.05.013","article-title":"p38 MAPK is involved in human neutrophil chemotaxis induced by L-amino acid oxidase from Calloselasma rhodosthoma","volume":"119","author":"Pontes","year":"2016","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0500","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1101\/gad.277681.116","article-title":"Distinctive properties of metastasis-initiating cells","volume":"30","author":"Celia-Terrassa","year":"2016","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.006_bib0505","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrm2957","article-title":"Cell adhesion: integrating cytoskeletal dynamics and cellular tension","volume":"11","author":"Parsons","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0510","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12551-013-0124-0","article-title":"Structural and mechanical functions of integrins","volume":"6","author":"Anderson","year":"2014","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0515","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.12688\/f1000research.11877.1","article-title":"Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment","volume":"6","author":"Longmate","year":"2017","journal-title":"F1000Res"},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0520","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9070084","article-title":"Integrin alphavbeta3 signaling in tumor-induced bone disease","volume":"9","author":"Kwakwa","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0525","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2017.06.012","article-title":"The roles of integrin alphavbeta6 in cancer","volume":"403","author":"Niu","year":"2017","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0530","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020044","article-title":"Integrin inhibitors in prostate cancer","volume":"10","author":"Juan-Rivera","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0535","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2013.00222","article-title":"Tumor targeting via Integrin Ligands","volume":"3","author":"Marelli","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0540","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1038\/srep39805","article-title":"A comprehensive evaluation of the activity and selectivity profile of Ligands for RGD-binding integrins","volume":"7","author":"Kapp","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0545","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.toxicon.2011.07.004","article-title":"Non-RGD-containing snake venom disintegrins, functional and structural relations","volume":"58","author":"Walsh","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0550","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2012.09.005","article-title":"The continuing saga of snake venom disintegrins","volume":"62","author":"Calvete","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0555","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biochi.2015.07.005","article-title":"talus simus tzabcan venom: isolation, characterization and evaluation of the cytotoxic and anti-adhesion activities of tzabcanin, a new RGD disintegrin","volume":"116","author":"Saviola","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0560","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijbiomac.2016.04.008","article-title":"The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells","volume":"88","author":"Saviola","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0565","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jprot.2014.11.016","article-title":"Proteomic and functional analyses of the venom of Porthidium lansbergii lansbergii (Lansberg\u2019s hognose viper) from the Atlantic Department of Colombia","volume":"114","author":"Jimenez-Charris","year":"2015","journal-title":"J. Proteomics"},{"issue":"22","key":"10.1016\/j.semcancer.2020.05.006_bib0570","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2174\/1568026619666190806151401","article-title":"Antitumoral potential of lansbermin-I, a novel disintegrin from Porthidium lansbergii lansbergii venom on breast cancer cells","volume":"19","author":"Montealegre-Sanchez","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40409-018-0150-2","article-title":"Alternagin-C binding to alpha2beta1 integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells","volume":"24","author":"Moritz","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0580","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40409-018-0167-6","article-title":"Cell migration inhibition activity of a non-RGD disintegrin from Crotalus durissus collilineatus venom","volume":"24","author":"Oliveira","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0585","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/abbi.2000.2120","article-title":"The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion","volume":"384","author":"Souza","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"18","key":"10.1016\/j.semcancer.2020.05.006_bib0590","doi-asserted-by":"crossref","first-page":"18247","DOI":"10.1074\/jbc.M311771200","article-title":"Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro","volume":"279","author":"Cominetti","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176226","article-title":"Inhibition of alphavbeta3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)","volume":"12","author":"Montenegro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118536","article-title":"Alphavbeta3 integrin blocking inhibits apoptosis and induces autophagy in murine breast tumor cells","author":"Lino","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0605","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.matbio.2012.11.015","article-title":"PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells","volume":"32","author":"Morjen","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.toxicon.2014.04.010","article-title":"Lebecin, a new C-type lectin like protein from Macrovipera lebetina venom with anti-tumor activity against the breast cancer cell line MDA-MB231","volume":"86","author":"Jebali","year":"2014","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrm.2015.14","article-title":"The front and rear of collective cell migration","volume":"17","author":"Mayor","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0620","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.28997","article-title":"Rho GTPases in collective cell migration","volume":"5","author":"Zegers","year":"2014","journal-title":"Small GTPases"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40409-015-0038-3","article-title":"Snake venom galactoside-binding lectins: a structural and functional overview","volume":"21","author":"Sartim","year":"2015","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0630","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxicon.2016.12.013","article-title":"Daboialectin, a C-type lectin from Russell\u2019s viper venom induces cytoskeletal damage and apoptosis in human lung cancer cells in vitro","volume":"127","author":"Pathan","year":"2017","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0635","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/15216549800201992","article-title":"Isolation and characterization of a new lectin from the venom of the snake Bothrops jararacussu","volume":"44","author":"Carvalho","year":"1998","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0640","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2011.10.012","article-title":"BJcuL, a lectin purified from Bothrops jararacussu venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly","volume":"59","author":"Nolte","year":"2012","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0645","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0041-0101(01)00106-4","article-title":"Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells","volume":"39","author":"de Carvalho","year":"2001","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.006_bib0650","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1878-0261.12092","article-title":"Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system","volume":"11","author":"Karlsson","year":"2017","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.006_bib0655","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0660","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ctrv.2011.11.001","article-title":"Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact","volume":"38","author":"Foroni","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"5\u20136","key":"10.1016\/j.semcancer.2020.05.006_bib0665","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2012.05.003","article-title":"The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity","volume":"22","author":"Nieto","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0670","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr2416","article-title":"Epithelial to mesenchymal transition and breast cancer","volume":"11","author":"Tomaskovic-Crook","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0675","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0680","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","article-title":"Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence","volume":"14","author":"Ansieau","year":"2008","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0685","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/jmbi.1994.1082","article-title":"Cardiotoxin III from the Taiwan cobra (Naja naja atra). Determination of structure in solution and comparison with short neurotoxins","volume":"235","author":"Bhaskaran","year":"1994","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0690","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cbf.3041","article-title":"Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells","volume":"32","author":"Tsai","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0695","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbt.21735","article-title":"Cardiotoxin III inhibits hepatocyte growth factor-induced epithelial-mesenchymal transition and suppresses invasion of MDA-MB-231 cells","volume":"30","author":"Tsai","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0700","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.toxicon.2016.01.051","article-title":"Taiwan cobra cardiotoxin III suppresses EGF\/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells","volume":"111","author":"Tsai","year":"2016","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0705","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovic","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.006_bib0710","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1515\/BC.2004.132","article-title":"Cysteine cathepsins in human cancer","volume":"385","author":"Jedeszko","year":"2004","journal-title":"Biol. Chem."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0715","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ijbiomac.2017.04.071","article-title":"Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions","volume":"102","author":"Shamsi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"Pt 1","key":"10.1016\/j.semcancer.2020.05.006_bib0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/bj3310239","article-title":"Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom","volume":"331","author":"Brillard-Bourdet","year":"1998","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0725","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12272-011-0512-6","article-title":"Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition","volume":"34","author":"Tang","year":"2011","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0730","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1871520611313040015","article-title":"Recombinant snake venom cystatin inhibits tumor angiogenesis in vitro and in vivo associated with downregulation of VEGF-A165, Flt-1 and bFGF","volume":"13","author":"Xie","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0735","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"Suppl","key":"10.1016\/j.semcancer.2020.05.006_bib0740","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0745","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006478","article-title":"alphaV integrins in angiogenesis and cancer","volume":"1","author":"Weis","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3\u20134","key":"10.1016\/j.semcancer.2020.05.006_bib0750","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/lrb.2008.1011","article-title":"Roles of integrins in tumor angiogenesis and lymphangiogenesis","volume":"6","author":"Garmy-Susini","year":"2008","journal-title":"Lymphat. Res. Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0755","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0760","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biotechadv.2017.11.004","article-title":"Alphavbeta3 and alpha5beta1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?","volume":"36","author":"Rocha","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0765","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mc.22470","article-title":"Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression","volume":"56","author":"Zakraoui","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0770","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10585-007-9101-y","article-title":"A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis","volume":"25","author":"Ramos","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0775","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-019-0339-1","article-title":"Recombinant RGD-disintegrin DisBa-01 blocks integrin alphavbeta3 and impairs VEGF signaling in endothelial cells","volume":"17","author":"Danilucci","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0780","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijbiomac.2017.01.064","article-title":"In vitro antitumor and antiangiogenic effects of Bothropoidin, a metalloproteinase from Bothrops pauloensis snake venom","volume":"97","author":"Guimaraes","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0785","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s10637-019-00734-2","article-title":"The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model","volume":"37","author":"Ghazaryan","year":"2019","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.semcancer.2020.05.006_bib0790","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijbiomac.2016.02.008","article-title":"CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis","volume":"86","author":"Ben-Mabrouk","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0795","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijbiomac.2018.05.230","article-title":"Targeting alpha1 inserted domain (I) of alpha1beta1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis","volume":"117","author":"Morjen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2020.05.006_bib0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pep.2016.09.021","article-title":"Towards universal approach for bacterial production of three-finger Ly6\/uPAR proteins: Case study of cytotoxin I from cobra N. oxiana","volume":"130","author":"Shulepko","year":"2017","journal-title":"Protein Expr. Purif."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.006_bib0805","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.toxicon.2011.02.020","article-title":"Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential","volume":"59","author":"Minea","year":"2012","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0810","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10080321","article-title":"Recombinant and chimeric disintegrins in preclinical research","volume":"10","author":"David","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.006_bib0815","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bbamcr.2008.01.011","article-title":"A presynaptically toxic secreted phospholipase A2 is internalized into motoneuron-like cells where it is rapidly translocated into the cytosol","volume":"1783","author":"Praznikar","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0820","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.expneurol.2009.07.017","article-title":"Ultrastructural evidence for the uptake of a neurotoxic snake venom phospholipase A2 into mammalian motor nerve terminals","volume":"219","author":"Logonder","year":"2009","journal-title":"Exp. Neurol."},{"issue":"49","key":"10.1016\/j.semcancer.2020.05.006_bib0825","doi-asserted-by":"crossref","first-page":"34013","DOI":"10.1074\/jbc.M803243200","article-title":"Snake phospholipase A2 neurotoxins enter neurons, bind specifically to mitochondria, and open their transition pores","volume":"283","author":"Rigoni","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.006_bib0830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/096032719901800202","article-title":"The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line","volume":"18","author":"Wang","year":"1999","journal-title":"Hum. Exp. Toxicol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.006_bib0835","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1159\/000366366","article-title":"Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles","volume":"34","author":"Badr","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.006_bib0840","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.bmc.2017.09.029","article-title":"Peptide therapeutics from venom: current status and potential","volume":"26","author":"Pennington","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"5230","key":"10.1016\/j.semcancer.2020.05.006_bib0845","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/225379a0","article-title":"Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme","volume":"225","author":"Ferreira","year":"1970","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.semcancer.2020.05.006_bib0850","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids","volume":"16","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.006_bib0855","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/13543784.17.8.1225","article-title":"Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme","volume":"17","author":"Reardon","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.006_bib0860","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2217\/fon.11.8","article-title":"Cilengitide: an RGD pentapeptide alphanubeta3 and alphanubeta5 integrin inhibitor in development for glioblastoma and other malignancies","volume":"7","author":"Reardon","year":"2011","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.006_bib0865","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/med.21377","article-title":"Strategies for the optimization of natural leads to anticancer drugs or drug candidates","volume":"36","author":"Xiao","year":"2016","journal-title":"Med. Res. Rev."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:41:48Z","timestamp":1778582508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X20301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":173,"alternative-id":["S1044579X20301024"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}